{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T04:42:41Z","timestamp":1786164161564,"version":"build-2736575974"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10198-025-01846-8","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T08:29:29Z","timestamp":1766996969000},"page":"1149-1169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the economic burden of complicated urinary tract infection: A systematic literature review"],"prefix":"10.1007","volume":"27","author":[{"given":"Edward","family":"Broughton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4164-7524","authenticated-orcid":false,"given":"Ann","family":"Colosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8080-7557","authenticated-orcid":false,"given":"Meryem","family":"Bektas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Kuper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Kotb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"1846_CR1","volume-title":"Urinary Tract Infection (Nursing)","author":"MJ Bono","year":"2023","unstructured":"Bono, M.J., Leslie, S.W., Reygaert, W.C., Doerr, C.: Urinary Tract Infection (Nursing). StatPearls Publishing, Treasure Island, FL (2023)"},{"issue":"10","key":"1846_CR2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41585-020-0362-4","volume":"17","author":"FME Wagenlehner","year":"2020","unstructured":"Wagenlehner, F.M.E., Bjerklund Johansen, T.E., Cai, T., Koves, B., Kranz, J., Pilatz, A., et al.: Epidemiology, definition and treatment of complicated urinary tract infections. Nat. Rev. Urol. 17(10), 586\u2013600 (2020)","journal-title":"Nat. Rev. Urol."},{"key":"1846_CR3","volume-title":"Complicated Urinary Tract Infections","author":"A Sabih","year":"2023","unstructured":"Sabih, A., Leslie, S.W.: Complicated Urinary Tract Infections. StatPearls Publishing, Treasure Island, FL (2023)"},{"issue":"2","key":"1846_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/cid\/ciac268","volume":"75","author":"PD Tamma","year":"2022","unstructured":"Tamma, P.D., Aitken, S.L., Bonomo, R.A., Mathers, A.J., van Duin, D., Clancy, C.J.: Infectious diseases society of America 2022 guidance on the treatment of extended-spectrum beta-lactamase producing enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin. Infect. Dis. 75(2), 187\u2013212 (2022)","journal-title":"Clin. Infect. Dis."},{"key":"1846_CR5","unstructured":"Balyayeva, M., Leslie, S.W., Jeong, J.M.: Acute Pyelonephritis. StatPearls Publishing (2024). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519537\/ Treasure Island (FL)"},{"key":"1846_CR6","unstructured":"Hammelman, E., Smith, A., Reese, J., Rodriguez, M.: Medicare spending on urinary tract infections: A retrospective database analysis. Presented IDWeek ; 29 September-3 October 2021. Virtual. (2021). https:\/\/assets.website-files.com\/61ef41452ab738bae2ccbefc\/620217b62ba424888ceb2299_IDWeek%202021%20-%20Poster%201416.pdf"},{"issue":"5","key":"1846_CR7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/antibiotics11050578","volume":"11","author":"TP Lodise","year":"2022","unstructured":"Lodise, T.P., Nowak, M., Rodriguez, M.: The 30-day economic burden of newly diagnosed complicated urinary tract infections in medicare fee-for-service patients who resided in the community. Antibiotics 11(5), 578 (2022)","journal-title":"Antibiotics"},{"issue":"11","key":"1846_CR8","doi-asserted-by":"publisher","first-page":"ofz446","DOI":"10.1093\/ofid\/ofz446","volume":"6","author":"JJ Carreno","year":"2019","unstructured":"Carreno, J.J., Tam, I.M., Meyers, J.L., Esterberg, E., Candrilli, S.D., Lodise, T.P. Jr.: Longitudinal, nationwide, cohort study to assess incidence, outcomes, and costs associated with complicated urinary tract infection. Open. Forum Infect. Dis. 6(11), ofz446 (2019)","journal-title":"Open. Forum Infect. Dis."},{"issue":"3","key":"1846_CR9","doi-asserted-by":"publisher","first-page":"219e211","DOI":"10.1016\/j.ajog.2013.10.006","volume":"210","author":"DA Wing","year":"2014","unstructured":"Wing, D.A., Fassett, M.J., Getahun, D.: Acute pyelonephritis in pregnancy: An 18-year retrospective Analysis. Am. J. Obstet. Gynecol. 210(3), 219e211\u2013219e216 (2014)","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"1846_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab591","volume":"9","author":"MD Zilberberg","year":"2022","unstructured":"Zilberberg, M.D., Nathanson, B.H., Sulham, K., Shorr, A.F.: Descriptive epidemiology and outcomes of hospitalizations with complicated urinary tract infections in the united States, 2018. Open Forum Infectious Diseases 9(1), ofab591 (2022)","journal-title":"Open Forum Infectious Diseases"},{"issue":"2","key":"1846_CR11","doi-asserted-by":"publisher","first-page":"e022137","DOI":"10.1136\/bmjopen-2018-022137","volume":"9","author":"AS Letica-Kriegel","year":"2019","unstructured":"Letica-Kriegel, A.S., Salmasian, H., Vawdrey, D.K., Youngerman, B.E., Green, R.A., Furuya, E.Y., et al.: Identifying the risk factors for catheter-associated urinary tract infections: A large cross-sectional study of six hospitals. BMJ Open. 9(2), e022137 (2019)","journal-title":"BMJ Open."},{"issue":"6","key":"1846_CR12","first-page":"541","volume":"68","author":"E Jim\u00e9nez-Alcaide","year":"2015","unstructured":"Jim\u00e9nez-Alcaide, E., Medina-Polo, J., Garc\u00eda-Gonz\u00e1lez, L., Arr\u00e9bola-Pajares, A., Guerrero-Ramos, F., P\u00e9rez-Cadavid, S., et al.: Healthcare-associated urinary tract infections in patients with a urinary catheter: Risk factors, Microbiological characteristics and patterns of antibiotic resistance. Arch. Esp. Urol. 68(6), 541\u2013550 (2015)","journal-title":"Arch. Esp. Urol."},{"issue":"10","key":"1846_CR13","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1097\/PCC.0000000000001628","volume":"19","author":"K Fukuoka","year":"2018","unstructured":"Fukuoka, K., Furuichi, M., Ito, K., Morikawa, Y., Watanabe, I., Shimizu, N., et al.: Longer duration of urinary catheterization increases catheter-associated urinary tract infection in PICU. Pediatr. Crit. Care Med. 19(10), e547\u2013e550 (2018)","journal-title":"Pediatr. Crit. Care Med."},{"issue":"1","key":"1846_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ajic.2013.06.026","volume":"42","author":"KR Daniels","year":"2014","unstructured":"Daniels, K.R., Lee, G.C., Frei, C.R.: Trends in catheter-associated urinary tract infections among a National cohort of hospitalized adults, 2001\u20132010. American Journal of Infection Control 42(1), 17\u201322 (2014)","journal-title":"American Journal of Infection Control"},{"issue":"7","key":"1846_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ajic.2015.02.011","volume":"43","author":"P Barbadoro","year":"2015","unstructured":"Barbadoro, P., Labricciosa, F.M., Recanatini, C., Gori, G., Tirabassi, F., Martini, E., et al.: Catheter-associated urinary tract infection: Role of the setting of catheter insertion. Am. J. Infect. Control 43(7), 707\u2013710 (2015)","journal-title":"Am. J. Infect. Control"},{"key":"1846_CR16","unstructured":"European Centre for Disease Prevention and Control. Healthcare-associated infections acquired in intensive care units\u2014annual epidemiological report for 2019: (2023). https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/healthcare-associated-infections-intensive-care-units-annual-epidemiological-report-2019.pdf. Accessed 10 Oct 2023"},{"issue":"Suppl 1A","key":"1846_CR17","doi-asserted-by":"publisher","first-page":"5s","DOI":"10.1016\/S0002-9343(02)01054-9","volume":"113","author":"B Foxman","year":"2002","unstructured":"Foxman, B.: Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 113(Suppl 1A), 5s\u201313s (2002)","journal-title":"Am. J. Med."},{"issue":"11","key":"1846_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2165\/00019053-200523110-00005","volume":"23","author":"P Brown","year":"2005","unstructured":"Brown, P., Ki, M., Foxman, B.: Acute pyelonephritis among adults: Cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics. 23(11), 1123\u20131142 (2005)","journal-title":"Pharmacoeconomics"},{"issue":"4 Pt 2","key":"1846_CR19","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1097\/00005392-200210020-00015","volume":"168","author":"T Mazzulli","year":"2002","unstructured":"Mazzulli, T.: Resistance trends in urinary tract pathogens and impact on management. Journal of Urology 168(4 Pt 2), 1720\u20131722 (2002)","journal-title":"Journal of Urology"},{"key":"1846_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-025-01149-8","author":"E Broughton","year":"2025","unstructured":"Broughton, E., Bektas, M., Colosia, A., Kuper, K., Fernandez, M.M., Al-Taie, A., et al.: A Systematic Literature Review of the Epidemiology of Complicated Urinary Tract Infection. Infect Dis Ther (2025). https:\/\/doi.org\/10.1007\/s40121-025-01149-8","journal-title":"Infect Dis Ther"},{"issue":"7","key":"1846_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad332","volume":"10","author":"MP Bilsen","year":"2023","unstructured":"Bilsen, M.P., Jongeneel, R.M.H., Schneeberger, C., Platteel, T.N., van Nieuwkoop, C., Mody, L., et al.: Definitions of urinary tract infection in current research: A systematic review. Open Forum Infectious Diseases 10(7), ofad332 (2023)","journal-title":"Open Forum Infectious Diseases"},{"issue":"1","key":"1846_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/00005650-200301000-00007","volume":"41","author":"CF Chiou","year":"2003","unstructured":"Chiou, C.F., Hay, J.W., Wallace, J.F., Bloom, B.S., Neumann, P.J., Sullivan, S.D., et al.: Development and validation of a grading system for the quality of cost-effectiveness studies. Med. Care 41(1), 32\u201344 (2003)","journal-title":"Med. Care"},{"issue":"1","key":"1846_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.18553\/jmcp.2003.9.1.53","volume":"9","author":"JJ Ofman","year":"2003","unstructured":"Ofman, J.J., Sullivan, S.D., Neumann, P.J., Chiou, C.F., Henning, J.M., Wade, S.W., et al.: Examining the value and quality of health economic analyses: Implications of utilizing the QHES. Journal of Managed Care Pharmacy 9(1), 53\u201361 (2003)","journal-title":"Journal of Managed Care Pharmacy"},{"key":"1846_CR24","unstructured":"Walker, D.G., Wilson, R.F., Sharma, R., Bridges, J., Niessen, L., Bass, E.B., et al.: Best practices for conducting economic evaluations in health care: a systematic review of quality assessment tools. Rockville, MD (2012). https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23230577"},{"key":"1846_CR25","doi-asserted-by":"publisher","first-page":"e544","DOI":"10.1097\/JU.0000000000003277.20","volume":"209","author":"M Nagpal","year":"2023","unstructured":"Nagpal, M., Chu, J., Dobberfuhl, A.: Cost of urinary tract infections with and without antibiotic resistance in the united States from 2012\u20132019. J. Urol. 209, e544 (2023) https:\/\/doi.org\/10.1097\/JU.0000000000003277.20","journal-title":"J. Urol."},{"issue":"2","key":"1846_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jmii.2014.12.010","volume":"49","author":"HA Lin","year":"2016","unstructured":"Lin, H.A., Yang, Y.S., Wang, J.X., Lin, H.C., Lin, D.Y., Chiu, C.H., et al.: Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and Levofloxacin in treatment of community-acquired complicated urinary tract infections. J. Microbiol. Immunol. Infect. 49(2), 237\u2013242 (2016)","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"2","key":"1846_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11255-013-0524-x","volume":"46","author":"J Colli","year":"2014","unstructured":"Colli, J., Tojuola, B., Patterson, A.L., Ledbetter, C., Wake, R.W.: National trends in hospitalization from indwelling urinary catheter complications, 2001\u20132010. Int. Urol. Nephrol. 46(2), 303\u2013308 (2014)","journal-title":"Int. Urol. Nephrol."},{"issue":"3","key":"1846_CR28","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1542\/peds.2015-1386","volume":"136","author":"A Goudie","year":"2015","unstructured":"Goudie, A., Dynan, L., Brady, P.W., Fieldston, E., Brilli, R.J., Walsh, K.E.: Costs of venous thromboembolism, catheter-associated urinary tract infection, and pressure ulcer. Pediatrics. 136(3), 432\u2013439 (2015)","journal-title":"Pediatrics"},{"issue":"6","key":"1846_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/MLR.0000000000000106","volume":"52","author":"SH Yi","year":"2014","unstructured":"Yi, S.H., Baggs, J., Gould, C.V., Scott, R.D. 2nd, Jernigan, J.A.: Medicare reimbursement attributable to catheter-associated urinary tract infection in the inpatient setting: A retrospective cohort analysis. Med. Care. 52(6), 469\u2013478 (2014)","journal-title":"Med. Care"},{"issue":"6","key":"1846_CR30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jinf.2015.08.012","volume":"71","author":"E Esteve-Palau","year":"2015","unstructured":"Esteve-Palau, E., Solande, G., S\u00e1nchez, F., Sorl\u00ed, L., Montero, M., G\u00fcerri, R., et al.: Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study. J. Infect. 71(6), 667\u2013674 (2015)","journal-title":"J. Infect."},{"issue":"4","key":"1846_CR31","doi-asserted-by":"publisher","first-page":"e020251","DOI":"10.1136\/bmjopen-2017-020251","volume":"8","author":"L Vallejo-Torres","year":"2018","unstructured":"Vallejo-Torres, L., Pujol, M., Shaw, E., Wiegand, I., Vigo, J.M., Stoddart, M., et al.: Cost of hospitalised patients due to complicated urinary tract infections: A retrospective observational study in countries with high prevalence of multidrug-resistant gram-negative bacteria: The COMBACTE-MAGNET, RESCUING study. BMJ Open 8(4), e020251 (2018) https:\/\/doi.org\/10.1136\/bmjopen-2017-020251","journal-title":"BMJ Open"},{"key":"1846_CR32","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.2147\/TCRM.S143358","volume":"13","author":"X Li","year":"2017","unstructured":"Li, X., Chen, Y., Gao, W., Ye, H., Shen, Z., Wen, Z., et al.: A 6-year study of complicated urinary tract infections in Southern china: prevalence, antibiotic resistance, clinical and economic outcomes. Ther. Clin. Risk Manag. 13, 1479\u20131487 (2017)","journal-title":"Ther. Clin. Risk Manag"},{"issue":"2","key":"1846_CR33","doi-asserted-by":"publisher","first-page":"e12694","DOI":"10.1002\/emp2.12694","volume":"3","author":"MD Zilberberg","year":"2022","unstructured":"Zilberberg, M.D., Nathanson, B.H., Sulham, K., Shorr, A.F.: Descriptive epidemiology and outcomes of emergency department visits with complicated urinary tract infections in the united States, 2016\u20132018. JACEP Open 3(2), e12694 (2022)","journal-title":"JACEP Open"},{"issue":"1","key":"1846_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12879-021-05842-0","volume":"21","author":"MD Zilberberg","year":"2021","unstructured":"Zilberberg, M.D., Nathanson, B.H., Sulham, K., Shorr, A.F.: Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013\u20132018: A retrospective cohort study. BMC Infect. Dis. 21(1), 159 (2021)","journal-title":"BMC Infect. Dis."},{"issue":"9","key":"1846_CR35","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/j.clinthera.2015.06.013","volume":"37","author":"RM Turner","year":"2015","unstructured":"Turner, R.M., Wu, B., Lawrence, K., Hackett, J., Karve, S., Tunceli, O.: Assessment of outpatient and inpatient antibiotic treatment patterns and health care costs of patients with complicated urinary tract infections. Clin. Ther. 37(9), 2037\u20132047 (2015)","journal-title":"Clin. Ther."},{"issue":"1","key":"1846_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jhin.2018.11.018","volume":"102","author":"YP Tabak","year":"2019","unstructured":"Tabak, Y.P., Sung, A.H., Ye, G., Vankeepuram, L., Gupta, V., McCann, E.: Attributable clinical and economic burden of carbapenem-non-susceptible gram-negative infections in patients hospitalized with complicated urinary tract infections. J. Hosp. Infect. 102(1), 37\u201344 (2019)","journal-title":"J. Hosp. Infect."},{"issue":"7","key":"1846_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac307","volume":"9","author":"TP Lodise","year":"2022","unstructured":"Lodise, T.P., Manjelievskaia, J., Marchlewicz, E.H., Rodriguez, M.: Retrospective cohort study of the 12-month epidemiology, treatment patterns, outcomes, and health care costs among adult patients with complicated urinary tract infections. Open Forum Infectious Diseases 9(7), ofac307 (2022)","journal-title":"Open Forum Infectious Diseases"},{"issue":"12","key":"1846_CR38","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.ajic.2021.05.013","volume":"49","author":"TP Lodise","year":"2021","unstructured":"Lodise, T.P., Chopra, T., Nathanson, B.H., Sulham, K.: Hospital admission patterns of adult patients with complicated urinary tract infections who present to the hospital by disease acuity and comorbid conditions: How many admissions are potentially avoidable? Am. J. Infect. Control 49(12), 1528\u20131534 (2021)","journal-title":"Am. J. Infect. Control"},{"issue":"1","key":"1846_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/21548331.2016.1133214","volume":"44","author":"SM Cardwell","year":"2016","unstructured":"Cardwell, S.M., Crandon, J.L., Nicolau, D.P., McClure, M.H., Nailor, M.D.: Epidemiology and economics of adult patients hospitalized with urinary tract infections. Hosp Pract (1995). 44(1), 33\u201340 (2016)","journal-title":"Hosp Pract (1995)"},{"issue":"4","key":"1846_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/jhm.2157","volume":"9","author":"SH MacVane","year":"2014","unstructured":"MacVane, S.H., Tuttle, L.O., Nicolau, D.P.: Impact of extended-spectrum \u03b2-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J. Hosp. Med. 9(4), 232\u2013238 (2014)","journal-title":"J. Hosp. Med."},{"issue":"3","key":"1846_CR41","doi-asserted-by":"publisher","first-page":"106541","DOI":"10.1016\/j.ijantimicag.2022.106541","volume":"59","author":"KC Gamble","year":"2022","unstructured":"Gamble, K.C., Rose, D.T., Sapozhnikov, J.: Intravenous to oral antibiotics versus intravenous antibiotics: A step-up or A step-down for extended spectrum \u03b2-lactamase (ESBL)-producing urinary tract infections without concomitant bacteraemia? Int. J. Antimicrob. Agents. 59(3), 106541 (2022)","journal-title":"Int. J. Antimicrob. Agents"},{"key":"1846_CR42","doi-asserted-by":"crossref","unstructured":"Zhang, H., Ohnuma, T., Spellman, A., Raghunathan, K., Krishnamoorthy, V., Anderson, D.J.: Healthcare utilization among older adults hospitalized with complicated urinary tract infections in the United States [Abstract 2847]. Presented at the IDWeek; 11\u201315 October 2023. Boston, MA.","DOI":"10.1093\/ofid\/ofad500.2457"},{"key":"1846_CR43","doi-asserted-by":"publisher","first-page":"1093842","DOI":"10.3389\/fcimb.2023.1093842","volume":"13","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Yan, C.Y., Li, S.R., Fan, T.T., Cao, S.S., Cui, B., et al.: Efficacy and safety of piperacillin-tazobactam compared with meropenem in treating complicated urinary tract infections including acute pyelonephritis due to extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae. Front. Cell. Infect. Microbiol. 13, 1093842 (2023)","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"1846_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/cid\/ciy418","volume":"68","author":"N Eliakim-Raz","year":"2019","unstructured":"Eliakim-Raz, N., Babitch, T., Shaw, E., Addy, I., Wiegand, I., Vank, C., et al.: Risk factors for treatment failure and mortality among hospitalized patients with complicated urinary tract infection: A multicenter retrospective cohort study (RESCUING study group). Clin. Infect. Dis. 68(1), 29\u201336 (2019)","journal-title":"Clin. Infect. Dis."},{"key":"1846_CR45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13756-019-0656-6","volume":"8","author":"A Gomila","year":"2019","unstructured":"Gomila, A., Carratal\u00e0, J., Eliakim-Raz, N., Shaw, E., Teb\u00e9, C., Wolkewitz, M., et al.: Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: The COMBACTE-MAGNET RESCUING study. Antimicrob. Resist. Infect. Control. 8, 198 (2019)","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"6","key":"1846_CR46","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/jac\/dkw035","volume":"71","author":"AL Hobbs","year":"2016","unstructured":"Hobbs, A.L., Shea, K.M., Daley, M.J., Huth, R.G., Jaso, T.C., Bissett, J., et al.: Are first-generation cephalosporins obsolete? A retrospective, non-inferiority, cohort study comparing empirical therapy with Cefazolin versus ceftriaxone for acute pyelonephritis in hospitalized patients. J. Antimicrob. Chemother. 71(6), 1665\u20131671 (2016)","journal-title":"J. Antimicrob. Chemother."},{"key":"1846_CR47","doi-asserted-by":"publisher","unstructured":"Branton, A.C., Vu, C.H., Venugopalan, V., Santevecchi, B.A., Cherabuddi, K., Ramphal, R., et al.: Re-evaluation of cefepime or piperacillin\/tazobactam to decrease use of carbapenems in ESBL-producing enterobacterales urinary tract infections (reduce-UTI). JAC-Antimicrobial Resistance (2023). https:\/\/doi.org\/10.1093\/jacamr\/dlad021","DOI":"10.1093\/jacamr\/dlad021"},{"issue":"3","key":"1846_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac034","volume":"9","author":"DT Anderson","year":"2022","unstructured":"Anderson, D.T., Albrecht, B., Jones, K.A., Jacob, J.T., Sexton, M.E., Wiley, Z., et al.: Efficacy of noncarbapenem \u03b2-Lactams compared to carbapenems for extended-spectrum \u03b2-lactamase-producing enterobacterales urinary tract infections. Open Forum Infectious Diseases 9(3), ofac034 (2022)","journal-title":"Open Forum Infectious Diseases"},{"issue":"11","key":"1846_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11111511","volume":"11","author":"E Sendra","year":"2022","unstructured":"Sendra, E., L\u00f3pez Montesinos, I., Rodriguez-Alarc\u00f3n, A., Du, J., Siverio-Par\u00e9s, A., Arenas-Miras, M., et al.: Comparative analysis of complicated urinary tract infections caused by extensively drug-resistant Pseudomonas aeruginosa and extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae. Antibiotics 11(11), 1511 (2022)","journal-title":"Antibiotics"},{"key":"1846_CR50","unstructured":"Gomez-Zorrilla, S., Alonso-Carrillo, J., Echeverria-Esnal, D., Silverio, A., Sendra, E., Rodriguez-Alarc\u00f3n, A., et al.: Urinary bloodstream infections due to extended spectrum b-lactamases (esbl)-producing Escherichia coli in an observational cohort study: risk factors and clinical outcomes. Presented at 33rd European congress of clinical microbiology & infectious diseases (ECCMID); 15\u201318 April 2023. Copenhagen, Denmark."},{"issue":"5","key":"1846_CR51","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.21037\/apm-20-1052","volume":"9","author":"X Liu","year":"2020","unstructured":"Liu, X., Sai, F., Li, L., Zhu, C., Huang, H.: Clinical characteristics and risk factors of catheter-associated urinary tract infections caused by Klebsiella pneumoniae. Ann. Palliat. Med. 9(5), 2668\u20132677 (2020)","journal-title":"Ann. Palliat. Med."},{"issue":"1","key":"1846_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.annemergmed.2020.08.022","volume":"77","author":"DA Talan","year":"2021","unstructured":"Talan, D.A., Takhar, S.S., Krishnadasan, A., Mower, W.R., Pallin, D.J., Garg, M., et al.: Emergence of extended-spectrum \u03b2-lactamase urinary tract infections among hospitalized emergency department patients in the united States. Ann. Emerg. Med. 77(1), 32\u201343 (2021)","journal-title":"Ann. Emerg. Med."},{"issue":"8","key":"1846_CR53","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ajic.2014.05.006","volume":"42","author":"D Vincitorio","year":"2014","unstructured":"Vincitorio, D., Barbadoro, P., Pennacchietti, L., Pellegrini, I., Ponzio, D.S.: Risk factors for catheter-associated urinary tract infection in Italian elderly. Am. J. Infect. Control. 42(8), 898\u2013901 (2014)","journal-title":"Am. J. Infect. Control."},{"key":"1846_CR54","doi-asserted-by":"publisher","unstructured":"Bosch-Nicolau, P., Falc\u00f3, V., Vi\u00f1ado, B., Andreu, A., Len, O., Almirante, B., et al.: A cohort study of risk factors that influence empirical treatment of patients with acute pyelonephritis. Antimicrob. Agents Chemother. 61 (2017). https:\/\/doi.org\/10.1128\/aac.01317-01317","DOI":"10.1128\/aac.01317-01317"},{"key":"1846_CR55","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1186\/s12879-014-0639-4","volume":"14","author":"VA Buonaiuto","year":"2014","unstructured":"Buonaiuto, V.A., Marquez, I., De Toro, I., Joya, C., Ruiz-Mesa, J.D., Seara, R., et al.: Clinical and epidemiological features and prognosis of complicated pyelonephritis: A prospective observational single hospital-based study. BMC Infect. Dis. 14, 639 (2014)","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"1846_CR56","first-page":"27","volume":"29","author":"M Delgado Vicente","year":"2017","unstructured":"Delgado Vicente, M., Lecaroz Agara, M.C., Barrios Andr\u00e9s, J.L., Canut Blasco, A.: Acute complicated and uncomplicated pyelonephritis in the emergency department: process-of-care indicators and outcomes. Emergencias 29(1), 27\u201332 (2017)","journal-title":"Emergencias"},{"issue":"4","key":"1846_CR57","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1007\/s40121-021-00537-0","volume":"10","author":"S G\u00f3mez-Zorrilla","year":"2021","unstructured":"G\u00f3mez-Zorrilla, S., Becerra-Aparicio, F., L\u00f3pez Montesinos, I., Ruiz de Gopegui, E., Grau, I., Pintado, V., et al.: A large multicenter prospective study of community-onset healthcare associated bacteremic urinary tract infections in the era of multidrug resistance: Even worse than hospital acquired infections? Infect. Dis. Ther. 10(4), 2677\u20132699 (2021)","journal-title":"Infect. Dis. Ther."},{"issue":"5","key":"1846_CR58","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1177\/0897190014568380","volume":"29","author":"MT Hong","year":"2016","unstructured":"Hong, M.T., Seifert, C.F.: Clinical impact of discordant prescribing of fluoroquinolones and alternative treatments in Escherichia coli pyelonephritis. J. Pharm. Pract. 29(5), 467\u2013471 (2016)","journal-title":"J. Pharm. Pract."},{"issue":"7","key":"1846_CR59","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1086\/671000","volume":"34","author":"SS Lewis","year":"2013","unstructured":"Lewis, S.S., Knelson, L.P., Moehring, R.W., Chen, L.F., Sexton, D.J., Anderson, D.J.: Comparison of non-intensive care unit (ICU) versus ICU rates of catheter-associated urinary tract infection in community hospitals. Infect. Control Hosp. Epidemiol. 34(7), 744\u2013747 (2013)","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"8","key":"1846_CR60","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1017\/ice.2020.204","volume":"41","author":"ML Rinke","year":"2020","unstructured":"Rinke, M.L., Oyeku, S.O., Heo, M., Saiman, L., Zachariah, P., Rosenberg, R.E., et al.: Pediatric ambulatory catheter-associated urinary tract infections (CAUTIs): incidence, risk factors, and patient outcomes. Infect. Control Hosp. Epidemiol. 41(8), 891\u2013899 (2020)","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"2","key":"1846_CR61","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jhin.2017.09.029","volume":"98","author":"L Shallcross","year":"2018","unstructured":"Shallcross, L., Gaskell, K., Fox-Lewis, A., Bergstrom, M., Noursadeghi, M.: Mismatch between suspected pyelonephritis and Microbiological diagnosis: A cohort study from A UK teaching hospital. J. Hosp. Infect. 98(2), 219\u2013222 (2018)","journal-title":"J. Hosp. Infect."},{"key":"1846_CR62","doi-asserted-by":"publisher","first-page":"S911","DOI":"10.1093\/ofid\/ofac492.1849","volume":"9","author":"S Stefanos","year":"2022","unstructured":"Stefanos, S., Gant, J., Kermeen, S., Sakaan, S., Samarin, M., Gelfand, M.S., et al.: Assessing clinical cure of empiric piperacillin-tazobactam for ESBL urinary tract infections (ACCEPT-UTI). Open. Forum Infect. Dis. 9, S911 (2022)","journal-title":"Open. Forum Infect. Dis."},{"issue":"11","key":"1846_CR63","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1017\/ice.2015.172","volume":"36","author":"R Tedja","year":"2015","unstructured":"Tedja, R., Wentink, J., O\u2019Horo, J.C., Thompson, R., Sampathkumar, P.: Catheter-associated urinary tract infections in intensive care unit patients. Infect. Control Hosp. Epidemiol 36(11), 1330\u20131334 (2015)","journal-title":"Infect. Control Hosp. Epidemiol"},{"issue":"6","key":"1846_CR64","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/03007995.2023.2205227","volume":"39","author":"R Dillon","year":"2023","unstructured":"Dillon, R., Burton, T., Anderson, A.J., Seare, J., Puzniak, L.: Risk of relapse and readmission among hospitalized adults with carbapenem non-susceptible gram-negative infections. Curr. Med. Res. Opin. 39(6), 881\u2013888 (2023)","journal-title":"Curr. Med. Res. Opin."},{"issue":"6","key":"1846_CR65","doi-asserted-by":"publisher","first-page":"639","DOI":"10.37201\/req\/096.2021","volume":"34","author":"R Ferrer","year":"2021","unstructured":"Ferrer, R., Fari\u00f1as, M.C., Maseda, E., Salavert, M., Bou, G., D\u00edaz-Rega\u00f1\u00f3n, J., et al.: Clinical management of cUTI, cIAI, and HABP\/VABP attributable to carbapenem-resistant gram-negative infections in Spain. Rev. Esp. Quimioter. 34(6), 639\u2013650 (2021)","journal-title":"Rev. Esp. Quimioter"},{"issue":"10","key":"1846_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102817","volume":"11","author":"X Li","year":"2022","unstructured":"Li, X., Fan, H., Zi, H., Hu, H., Li, B., Huang, J., et al.: Global and regional burden of bacterial antimicrobial resistance in urinary tract infections in 2019. Journal of Clinical Medicine 11(10), 2817 (2022)","journal-title":"Journal of Clinical Medicine"},{"key":"1846_CR67","doi-asserted-by":"crossref","unstructured":"United Nations. Department of Economic and Social Affairs. World social report 2023: leaving no one behind in an ageing world: (2023). https:\/\/desapublications.un.org\/publications\/world-social-report-2023-leaving-no-one-behind-ageing-world. Accessed 26 Jul 2024","DOI":"10.18356\/9789210019682"},{"key":"1846_CR68","unstructured":"HICPAC. Centers for Disease Control and Prevention (CDC). Guideline for prevention of catheter associated urinary tract infections 2009: (2019). https:\/\/www.cdc.gov\/infection-control\/media\/pdfs\/Guideline-CAUTI-H.pdf. Accessed 10 Jun 2025"},{"key":"1846_CR69","unstructured":"NHSN. Centers for Disease Control and Prevention (CDC): Urinary Tract Infection (Catheter-Associated Urinary Tract Infection [CAUTI] and Non-Catheter-Associated Urinary Tract Infection [UTI]) Events January 2025. (2025). https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/7psccauticurrent.pdf. Accessed 10 Jun 2025"},{"key":"1846_CR70","doi-asserted-by":"publisher","unstructured":"Wickins, J., Rickard, C.M., Kasper, K., Morton, L., Doellinger, J., Thomas-Gabbett, P., et al.: Indwelling urinary catheter use and adherence to clinical practice guidelines: A point prevalence study in adult hospital inpatients. Journal of Infection Prevention (2024). https:\/\/doi.org\/10.1177\/17571774241270995","DOI":"10.1177\/17571774241270995"},{"issue":"1","key":"1846_CR71","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13741-020-00167-z","volume":"10","author":"TA Brouwer","year":"2021","unstructured":"Brouwer, T.A., van Roon, E.N., Rosier, P., Kalkman, C.J., Veeger, N.: Postoperative urinary retention: Risk factors, bladder filling rate And time to catheterization: An observational study as part of a randomized controlled trial. Perioper Med. (Lond). 10(1), 2 (2021)","journal-title":"Perioper Med. (Lond)"},{"key":"1846_CR72","doi-asserted-by":"crossref","unstructured":"Kamel, M., Harris, N., Berry, A., Warsavage, T., Bessesen, M.T., Kon, S.E.: Implementation of A nurse-driven protocol for indwelling urinary catheter removal and novel utilization dashboard: A pre\/postintervention observational study. Ther. Adv. Infect. Dis. 12, 20499361251317900 (2025)","DOI":"10.1177\/20499361251317900"},{"issue":"8","key":"1846_CR73","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1017\/ice.2023.137","volume":"44","author":"PK Patel","year":"2023","unstructured":"Patel, P.K., Advani, S.D., Kofman, A.D., Lo, E., Maragakis, L.L., Pegues, D.A., et al.: Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 update. Infect. Control Hosp. Epidemiol. 44(8), 1209\u20131231 (2023)","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"1846_CR74","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2147\/IDR.S382617","volume":"16","author":"J Marantidis","year":"2023","unstructured":"Marantidis, J., Sussman, R.D.: Unmet needs in complicated urinary tract infections: challenges, recommendations, and emerging treatment pathways. Infect. Drug Resist. 16, 1391\u20131405 (2023)","journal-title":"Infect. Drug Resist."},{"key":"1846_CR75","unstructured":"World Health, O., WHO bacterial priority pathogens list:, : bacterial pathogens of public health importance, to guide research, development and strategies to prevent and control antimicrobial resistance. World Health Organization, Geneva (2024). https:\/\/iris.who.int\/handle\/10665\/376776"},{"issue":"12","key":"1846_CR76","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1093\/cid\/ciac358","volume":"75","author":"Y Mo","year":"2022","unstructured":"Mo, Y.: Rapid diagnostics for antibiotic resistance: Urgent need for strong clinical evidence. Clin. Infect. Dis. 75(12), 2076\u20132078 (2022)","journal-title":"Clin. Infect. Dis."}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-025-01846-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-025-01846-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-025-01846-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:59:54Z","timestamp":1786161594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10198-025-01846-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1846"],"URL":"https:\/\/doi.org\/10.1007\/s10198-025-01846-8","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","label":"<b>Ethical approval<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MB and AC are full-time employees of RTI Health Solutions, an independent nonprofit research organization, which was retained by Pfizer to conduct the research that is the subject of this manuscript. Their compensation is unconnected to the studies on which they work. EB, KK, and RK are employees of Pfizer and hold stock in the company.\u00a0","order":2,"name":"Ethics","label":"<b>Competing interests<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}]}}